JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Large Drop in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 459,300 shares, a decline of 9.0% from the December 15th total of 505,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS:JCRRF opened at $4.57 on Monday. The stock has a 50-day simple moving average of $4.57 and a 200 day simple moving average of $4.58. JCR Pharmaceuticals has a 52-week low of $4.30 and a 52-week high of $4.70.

About JCR Pharmaceuticals

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.